Over the last decade, numerous studies and policies have focused on treatment decision models aimed at improving patient-provider communication, including shared decision making (SDM). SDM involves collaborative partnership between patients and providers who are both considered experts and are expected to participate in deliberation about treatment decisions (Charles, Gafni, & Whelan, 1997) . Studies in various clinical settings have found that patients prefer SDM (Adams, Drake, & Wolford, 2007; Betinger, Kissling, & Hamann, 2014; Goossensen, Ziilstra & Koopmanschap, 2007; Hamann, Cohen, Leucht, Busch, & Kissling, 2005; Hill & Laugharne, 2005; Matthias, Salyers, Rollins, & Frankel, 2012a) .
However, emerging studies examining actual patient behaviors reveal most patients play a passive role in decision-making (De Las Cuevas, Penate, Perestelo-Perez, & Serrano-Aguilar; Mahone et al., 2011; Protheroe, Brooks, Chew-Graham, Gardner, & Rogers, 2013; Tariman, Berry, Cochrane, Doorenbos, & Schepp, 2010) . These studies suggest factors other than patient preference might influence participation in treatment decision-making. Some studies attributed providers' reluctance to relinquish power as a factor that reduces SDM (Entwistle, Prior, Skea, & Francis; Goss et al., 2008) . Others suggested the severity of illness (Mahone, et al., 2011; Shepherd, Tattersall, & Butow, 2008) , and that individual characteristics of providers and patients, such as gender, age, and education also complicate patients' participation in treatment decisions (Galesic & Garcia-Retamero, 2011; McCabe, Khanom, Bailey, & Priebe, 2013; Uldry, Schäfer, Saadi, Rousson, & Demartines, 2013) . Numerous factors influence SDM, and patients' preferences alone do not ensure shared decision-making. Yet, little is known about patients' perspectives on factors that facilitate or hinder their involvement in treatment decisions (JosephWilliams, Elwyn, & Edwards, 2013) . More studies are needed to better understand the complexity of SDM, and what influences patients' participation in this model of decisionmaking.
Such understanding is important to address patient-level barriers and to facilitate implementation of SDM in mental health care. While some studies have examined SDM in outpatient mental health settings (Adams, Drake, & Wolford, 2007; De Las Cuevas, Penate, Perestelo-Perez, & Serrano-Aguilar, 2013; Fukui et al., 2014) , few have explored patients' appraisals of how treatment decisions are made in mental health. To better understand patientlevel factors that might influence participation in SDM we examined patients' perceptions of treatment decision-making with mental health providers.
Methods
Participants were recruited from a larger exploratory study on SDM using convenience sampling; patients were approached in the waiting room prior to their appointments. Seventynine patients agreed to have their appointments recorded; 54 (68%) participated in the interview portion following their appointment. Most common reasons for non-participation in the interview were lack of time and interest. Most participants were White, men, and over 40 years old (See   table 1 ). Participants' psychiatric conditions included mood disorders, PTSD, and schizophrenia; and most (66%) had worked with the same provider for 1 to 3 years. Participants signed written consents prior to the interviews.
Research procedures were approved by the by the local institutional review board and medical center research committee. Development of the interview protocol was guided by the literature and informal conversations with providers. Interviews were conducted by 4 trained research assistants, were semi-structured, and lasted about an hour. Questions focused on the patient-provider relationship, treatment decision-making, medication adherence, and illness management. All interviews were audio-recorded, transcribed, and imported into Atlas.ti computer program (2010), a qualitative analysis tool.
The authors analyzed the data using an inductive thematic approach (Braun and Clarke, 2006; Patton, 1990) , which involved identifying and comparing common emergent themes across transcripts. All 4 authors participated in the data analysis process to provide multiple perspectives, create consensus, and facilitate validity of the analysis. We individually read several transcripts to gain a general understanding of the data. We compared responses across transcripts to identify emergent themes. We developed a list of preliminary codes by labeling segments of the documents (Miles and Huberman, 1994) . We resolved inconsistencies in the coding structures through consensus. We reviewed the preliminary codes using an iterative approach in which codes were combined, eliminated, or expanded to best capture the data (Saldaña, 2009) . Throughout the data analysis process, we continually returned to the data to strengthen the analytical categories and search for verification or counter evidence (Bazeley, 2013) . Thematic saturation was established once no new variations of a given theme were identified, and based on evidence of repeated coding within the same category (Suter, 2012) .
Results:

Participants' preferences
Participants reported a broad range of preferences for participation in treatment decision-making. In contrast, a number of participants who had long relationships with their providers, which led to a deep trust, believed that not only were their providers capable, but they considered participants' best interests when deciding treatment. This trust led them to feel comfortable deferring decisions to their providers. Some participants chose a passive role in decision-making because they feared that a poor decision could significantly jeopardize their mental health. They reported they lack the medical knowledge or feel ill-equipped to make sound judgments about their mental health care. D32: Medication-wise, I pretty much leave that up to [Provider] . I don't know a thing about [medications]…If she gives it to me, I take it…I don't make any decisions about that.
Other barriers to SDM included fear of being judged, violating patient-physician role boundaries, or possible repercussions from providers. As an extreme example, a White male shared that his fear of losing his health services led to ineffective communication with his provider. Instead of trusting (or, alternatively, being honest with) his provider, he described how he "played along" with a provider to obtain his desired outcome. D39: One trainee wanted to do testing of anything that might cause depression …I'd already been through many years of this… I was like why are we doing this now? … The impression I got was, "we're gonna test to see if you really need this medication. If not, we're taking you off of it". . . . I went along with what she's saying. As we were leaving, I said, I'll make an effort and she said something like, "you definitely want to if you want to continue service." So, I'd made the decision. I was still getting my refills. I put it off and finally decided to totally ignore it, taking a chance. Ultimately, I did see a true psychiatrist and discussed it. . . . I've even brought up my fears of losing my medication.
Patient-provider disagreements
Participants also acknowledged that treatment decision-making can be fraught with disagreements. Their interviews highlight the negative impacts that disagreement can have on the patient-provider relationship. They also underscore the dynamic process of SDM and patients' attempts at managing discontent with providers. Below, a participant illustrates how treatment disagreement jeopardized her relationship and ability to communicate with her provider. Others overcame disagreement by discussing their concerns with their providers. In these cases, a strong patient-provider relationship facilitated these discussions, by encouraging patients to clarify their needs and preferences. It also cemented trust between patients and providers. D53: One time she was going to lower my medication and I let her know that I didn't think it would be a wise idea. I explained to her why and then she concurred with my decision. After we talked it out it was better that we left it at the same dosage. where I said I have tried it for two to three weeks and it doesn't seem to be doing me any good. . . . It did help. . . . I had my doubts, but I also thought, she's gotten me this far.
Issues of substance misuse also emerged during the interviews as a major point of tension in the patient-provider relationship and the process of decision-making. A few participants acknowledged that their history of substance use created concerns, frustration, even suspicions for providers, which in turn affected the patient-provider relationship and SDM.
D65: Since I told [Provider] I had a drug and alcohol problem some years ago…she was testing me every dayv I said, "Ma'am, you can test me 24 hours a day. I'm clean and sober." I just got tired of it . . . . She didn't like to listen. D4: Because I've used in the past, they won't give me drugs that will help me because they figure…I want to abuse it. . . I feel like whenever I talk to them about what worked for me, they look at me like "you're just wanting to get high." . . . I feel like they look at me wrong. I don't know if that's true. . . . that's the feeling I get.
Discussion and conclusion
Study results highlight the complexity of patient participation in SDM. Findings suggest that patients' willingness to participate in SDM might be independent of their understanding and opinions of shared decision-making. Instead, the patient-provider relationship and situational contexts play an important role in patients' participation. Even patients who expressed positive views of SDM reported preference at times for partial or minimal involvement in SDM, This study is based on a relatively small sample of patients at a single VA mental health clinic and focused only on patients' perspectives and historical accounts, which present a limited view of patient-provider communication. However, our findings are consistent with previous studies showing that patients have varied levels of preference for SDM. More importantly, our findings help to explain why these variations occur.
Our findings emphasize that the patient-provider relationship in mental health care is longitudinal and dynamic. Consequently, communication and SDM are likely to vary over time depending on the patient's needs. A cross-sectional study cannot capture these relational dynamics, which limits our understanding of SDM in the context of patient-provider relationships that might span many years (Matthias et al., 2013; McCabe 2013) . Indeed, our data suggest that during routine medication checks, some patients preferred to defer treatment decisions to their providers because they have a trusting, long-term relationship with them.
Although trust in providers might lead to deferring control over treatment decisions, it is not necessarily a barrier to SDM. Rather, over time, patients and providers might develop communication processes to meet their situational needs. Similarly, because mental health visits occur with regularity, all decisions might not require a complete SDM process. For many routine visits, decisions involve primarily review and adjustment of medication dosage, which might not require lengthy discussions. Thus, some participants noted it was appropriate to shorten the decision-making process, yet they still felt a sense of autonomy and partnership in their care.
Participants' flexible uses of varied elements of shared decision-making raise additional questions about how to assess and implement shared decision-making in chronic care. Future studies should include longitudinal data to answer these questions. 
